Evidence map›Paper›PMID 35790446›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[Berberine inhibits erastin-induced ferroptosis of mouse hippocampal neuronal cells possibly by activating the Nrf2-HO-1/GPX4 pathway].

Q Huang, D Ji, X Tian, L Ma, X Sun

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Comprehensive Analysis ofNutrients · 2024
    Article
  5. Article
  6. [Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axisNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Q HuangDepartment of Clinical Medicine, Biochemical Drugs Engineering and Technological Research Center of Anhui Province, Bengbu 233030, China.
D JiDepartment of Clinical Medicine, Biochemical Drugs Engineering and Technological Research Center of Anhui Province, Bengbu 233030, China.
X TianDepartment of Clinical Medicine, Biochemical Drugs Engineering and Technological Research Center of Anhui Province, Bengbu 233030, China.
L MaDepartment of Pharmacy, Bengbu Medical College, Biochemical Drugs Engineering and Technological Research Center of Anhui Province, Bengbu 233030, China.
X SunDepartment of Pharmacy, Bengbu Medical College, Biochemical Drugs Engineering and Technological Research Center of Anhui Province, Bengbu 233030, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the mechanism by which berberine inhibits ferroptosis of mouse hippocampal neuronal cells (HT22).

methodsCultured HT22 cells were pretreated with 30 or 60 μmol/L berberine for 2 h before exposure to 0.5 μmol/L erastin for 8 h, and the cell proliferation, intracellular ferric iron level, changes in intracellular reactive oxygen species (ROS) and cell apoptosis were detected using CCK-8, Fe

resultsTreatment with 0.5 μmol/L erastin significantly lowered the viability of HT22 cells (

conclusionBerberine can inhibit erastin-induced ferroptosis in HT22 cells possibly by activating the Nrf2-HO-1/ GPX4 pathway.

Indexed as

BerberineFerroptosisAnimalsFluorescent DyesHippocampusIronMiceNF-E2-Related Factor 2PiperazinesReactive Oxygen SpeciesBerberineerastinFluorescent DyesIronNF-E2-Related Factor 2PiperazinesReactive Oxygen SpeciesberberineerastinferroptosisHT22 cellsneuroprotectionNrf2-HO-1/GPX4

Identifiers

PMID35790446
PMCPMC9257364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.